The Saudi Arabian Ministry of Health (MOH) reported a new case of MERS-CoV over the weekend.
The 89-year-old Saudi man from Baljurashi in the southwestern part of the country is in stable condition after being diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). The source of his infection is listed as "primary," meaning it's unlikely he contracted the disease from another person.
A study today in BMC Infectious Diseases reports that patients with multidrug- and extensively drug-resistant tuberculosis (MDR- and XDR-TB) in China's Hunan province had low rates of treatment success.
The Saudi Arabian Ministry of Health (MOH) announced a new case of MERS-CoV today, continuing a small but steady stream of cases in the weeks leading up to the Hajj pilgrimage.
A detailed look at variant influenza cases from seven agricultural fairs in Michigan and Ohio in 2016 found that of 18 variant H3N2 (H3N2v) cases in humans, 16 were infected with a reassortant that contains the hemagglutinin gene from the 2010-2011 seasonal H3N2 strain in humans, a strain increasingly seen in US swine herds.
The Saudi Arabian Ministry of Health (MOH) reported a new case of MERS yesterday in a man from Riyadh.
The 47-year-old expatriate is in critical condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus). The man is not a healthcare worker, nor did he have contact with camels. The source of his infection is listed as primary, which means it's unlike he contracted it from anyone else.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A review of hospital-onset Pseudomonas aeruginosa infections in the United States found that the mortality from multidrug-resistant P aeruginosa (MDR-PSA) is nearly twice that of non-MDR-PSA infections.
A pharmacist-driven antimicrobial stewardship program (ASP) in intensive care units (ICUs) in eastern China was associated with decreased mortality, lowered emergence of multidrug resistance, and optimized use of antimicrobial agents, according to a study yesterday in the American Journal of Infection Control.
Two countries reported more highly pathogenic avian flu outbreaks: H5N8 in Russia and H5N2 in South Korea, according to notifications today from the World Organization for Animal Health (OIE).
Russia's outbreak began on May 4 in backyard birds in the Republic of Tatarstan in the west. The virus killed 13 of 51 birds, and authorities culled the remaining ones as part of the response measures.
A study yesterday in BMC Infectious Diseases indicates that piperacillin/tazobactam (PTZ) is effective in treating healthcare-associated urinary tract infection (UTI) caused by extended-spectrum, beta-lactamase-producing Escherichia coli (ESBL-EC), a type of infection for which therapeutic options are limited.
The World Health Organization (WHO) and the Global Polio Eradication Initiative (GPEI) confirmed today that there are at least three children with circulating vaccine-derived poliovirus type 2 in the Deir-Ez-Zor governorate of Syria. Two children have developed acute flaccid paralysis (AFP), and one child has tested positive for the virus but is currently healthy.
The Saudi Arabian Ministry of Health (MOH) reported six new cases of MERS-CoV today, all linked to one or more of the current hospital outbreaks in Riyadh.
Originally published by CIDRAP News Jun 8
In a new study on the Ebola vaccine that has already shown effectiveness in an earlier phase 3 trial during West Africa's outbreak, researchers found that antibodies persist at least for a year and that the vaccine was well tolerated.
Hospital patients who receive antibiotic treatment may face about a 20% risk of a related adverse event, if the results of a new study from Johns Hopkins University researchers can be generalized.
Nine Brazilian infants with congenital Zika infections developed moderate to severe dysphagia, or problems with swallowing, increasing the risk of aspirating liquids and choking, according to a report yesterday in Emerging Infectious Disease.
A single-center study in Egypt found that nearly two thirds of the Enterobacteriaceae isolates collected from the feces of patients who had community-onset gastrointestinal complaints were extended-spectrum beta-lactamase (ESBL) producers, and 4.4% were carbapenemase-producing Enterobacteriaceae (CPE).
Today the Saudi Arabian Ministry of Health (MOH) announced three new MERS-CoV cases in Riyadh.
Yesterday, the World Health Organization (WHO) said there were three separate hospital-based outbreaks of MERS-CoV (Middle East respiratory syndrome coronavirus) in that city. At least one of the new cases is tied to the hospital outbreaks, but none of the patients are healthcare workers.
Researchers looking for mutations that might make H7N9 avian influenza more easily transmissible among people identified three amino acid changes that would make the virus more likely to bind to human airway receptors. A team of researchers from the United States, including those from The Scripps Research Institute, and the Netherlands reported its findings today in PLoS Pathogens.
Today the Saudi Arabian Ministry of Health (MOH) reported a new case of MERS-CoV related to ongoing outbreaks in three Riyadh hospitals.
A 68-year-old male expatriate who had preexisting disease has died from MERS-CoV (Middle East respiratory syndrome coronavirus). He acquired the virus as a patient in a hospital.
A study of intensive care unit (ICU) patients in Ho Chi Minh City, Vietnam, showed high rates of antimicrobial-resistant bacterial infections, according to a report yesterday in BMC Infectious Diseases.
Only 10% of surgical procedures in Brazil involved full compliance with surgical antibiotic prophylaxis (SAP) guidelines, according to a new study in the American Journal of Infection Control.
The Saudi Arabian Ministry of Health (MOH) confirmed the diagnosis of three new cases of MERS-CoV in recent days, including one case in an asymptomatic healthcare worker at a hospital in Riyadh. At least three hospitals in Riyadh have reported MERS outbreaks this month.
A new fluoroquinolone antibiotic, delafloxacin (Baxdela), for acute bacterial skin and skin structure infections (ABSSSI) in adults gained approval yesterday from the US Food and Drug Administration (FDA), according to Melinta Therapeutics, the manufacturer.
